Connor, Clark & Lunn Investment Management (CC&L)’s Amphastar Pharmaceuticals AMPH Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-32,241
| Closed | -$935K | – | 1494 |
|
|
2025
Q1 | $935K | Sell |
32,241
-35,126
| -52% | -$1.02M | ﹤0.01% | 976 |
|
|
2024
Q4 | $2.5M | Sell |
67,367
-16,306
| -19% | -$605K | 0.01% | 666 |
|
|
2024
Q3 | $4.06M | Sell |
83,673
-20,448
| -20% | -$992K | 0.02% | 491 |
|
|
2024
Q2 | $4.16M | Buy |
104,121
+15,569
| +18% | +$623K | 0.02% | 466 |
|
|
2024
Q1 | $3.89M | Buy |
88,552
+47,388
| +115% | +$2.08M | 0.02% | 491 |
|
|
2023
Q4 | $2.55M | Buy |
41,164
+22,737
| +123% | +$1.41M | 0.01% | 609 |
|
|
2023
Q3 | $847K | Buy |
+18,427
| New | +$847K | ﹤0.01% | 867 |
|
|
2016
Q4 | – | Sell |
-13,817
| Closed | -$262K | – | 885 |
|
|
2016
Q3 | $262K | Sell |
13,817
-2,183
| -14% | -$41.4K | ﹤0.01% | 698 |
|
|
2016
Q2 | $258K | Sell |
16,000
-24,900
| -61% | -$402K | ﹤0.01% | 705 |
|
|
2016
Q1 | $491K | Sell |
40,900
-8,200
| -17% | -$98.4K | ﹤0.01% | 572 |
|
|
2015
Q4 | $699K | Buy |
49,100
+12,300
| +33% | +$175K | 0.01% | 499 |
|
|
2015
Q3 | $430K | Buy |
+36,800
| New | +$430K | ﹤0.01% | 546 |
|